Evaluation of the Safety and Efficacy of a Fractional Picosecond 1064 nm Laser for Post-acne Erythema in Adult Chinese Patients
Overview
Affiliations
Objective: To evaluate the efficacy and safety of fractional 1064 nm picosecond Nd:YAG laser (FPNYL) in the treatment of post-acne erythema (PAE) of adult Chinese.
Materials And Methods: A total of 22 patients received 1 session of treatment and were followed up at the eighth week. Primary outcomes were measured by the Clinician erythema assessment scale (CEAS). Secondary outcomes included a global aesthetic improvement scale (GAIS) and patients' assessment of satisfaction on a five-point scale. Pain scores and adverse effects were also evaluated.
Results: Twenty-two patients with Fitzpatrick skin types III and IV were enrolled in the study and completed all treatments and follow-up visits. The mean CEAS scores fell from 2.74 ± 0.80 to 1.95 ± 0.75 (p < 0.05). The mean GAIS of PAE improvement was 2.46 ± 0.68. Erythema percentile scores by VISIA increased from 32.63 ± 7.0 to 45.75 ± 11.45 (t = 5.442, p = 0). The patient satisfaction score was 1.86 ± 1.17. The pain scores were 3.27 ± 1.17 for the FPNYL treatment (varied from 2 to 6). There were moderate erythema and oedema, which last for 3.84 ± 0.78 days. There were overall 68.18% (15/22) patients who felt pruritus in different degrees and 27.27% patients who encountered acne eruptions (white head type). No scar, hyperpigmentation or hypopigmentation was found.
Conclusion: Treatment with fractional 1064 nm picosecond Nd:YAG laser is effective and safe for PAE of Chinese patients.
Li J, Duan F, Kuang J, Liu X, Pan J, Wei J Skin Res Technol. 2024; 30(7):e13856.
PMID: 39031924 PMC: 11259539. DOI: 10.1111/srt.13856.
Picosecond lasers in cosmetic dermatology: where are we now? An overview of types and indications.
Haykal D, Cartier H, Maire C, Mordon S Lasers Med Sci. 2023; 39(1):8.
PMID: 38110831 DOI: 10.1007/s10103-023-03945-5.
Jia X, Zheng L, Fang L, Zhang L, Wu Y, Yang Y Skin Res Technol. 2023; 29(1):e13274.
PMID: 36704883 PMC: 10155796. DOI: 10.1111/srt.13274.